Annotation Detail for GOLGA3
Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GOLGA3 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GOLGA3 mRNA | affects expression | 21346803
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GOLGA3 mRNA | increases expression | 20106945
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of GOLGA3 mRNA | increases expression | 19244175
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of GOLGA3 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.41 | 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.09 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.36 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.36 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
MESH:D003092 |
Colitis |
|
Selenium |
4.26 | 17936198 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.92 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.56 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.56 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.75 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.75 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.75 | 15131321 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.32 | 9068938 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.23 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.62 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.15 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.27 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.80 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.58 | 14716179 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
13.09 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
13.09 | 16624496 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.63 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.63 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.26 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
14.20 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
14.20 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
14.20 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.25 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 2876784 2876786 6135515 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.40 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
1.90 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.97 | 15318939 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.90 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
12.21 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
12.21 | 7678174 18551238 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 19348381 18481113 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.06 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
10.06 | 16049721 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.50 | 15087411 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.25 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.65 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.65 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.51 | 18709164 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.81 | 16517955 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.39 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.86 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.86 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |
PharmGKB Accession:PA28807
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |